Company: PIII
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001832511-25-000025
Chunk: 89

Company: P3 Health Partners Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 89
---
’ EQUITY, March 31, 2024$238,836 2,388 $— 3,930 $— $532,640 $(386,044)$146,596 Exchanges of redeemable non-controlling interest for Class A common stock— 11 — (11)— — — — Issuance of Class A common stock upon settlement of restricted stock units, net of shares withheld for tax— 4 — — — (30)— (30)Equity-based compensation— — — — — 1,624 — 1,624 Remeasurement adjustment to redeemable non-controlling interest resulting from ownership changes(24,095)— — — — 24,095 — 24,095 Private placement, net of offering costs— 832 — — — 6,575 — 6,575 Net loss(16,754)— — — — — (12,020)(12,020)STOCKHOLDERS’ EQUITY, June 30, 2024197,987 3,235 $— 3,919 $— $564,904 $(398,064)$166,840 Issuance of Class A common stock upon settlement of restricted stock units, net of shares withheld for tax— 4— —— — — — Equity-based compensation— —— —— 1,958 — 1,958 Remeasurement adjustment to redeemable non-controlling interest resulting from ownership changes1,748 —— —— (1,748)— (1,748)Private placement, net of offering costs— —— —— (24)— (24)Net loss(56,338)—— —— — (46,512)(46,512)STOCKHOLDERS’ EQUITY, September 30, 2024$143,397 3,239$— 3,919$— $565,090 $(444,576)$120,514 

P3 Health Partners Inc. | Q3 2025 Form 10-Q | 7

RedeemableNon-controllingInterestClass A Common StockClass V Common StockAdditional Paid in CapitalAccumulatedDeficitTotal Stockholders’Equity (Deficit)SharesAmountShares